Scientists at The Wistar Institute Clone Several New Anti-Interferon Antibodies - Developing Future Therapeutic Candidates with Broad Application Potential
Wistar InstituteWistar Institute scientists have successfully isolated and cloned fully human antibodies that can block specific Type-I interferon molecules in vitro; their discovery has an array of potential clinical & research applications, enabling scientists with a new way to investigate the role of specific Type-I interferons in a variety of diseases.